Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05747365
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2023-02-17
Brief Title:
Role of Endocrine Disruptors in Thyroid Cancer
Sponsor:
Istituto Auxologico Italiano
Organization:
Istituto Auxologico Italiano
Study Overview
Official Title:
Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
THY-ED
Brief Summary:
the relationship between human exposure to EDCS and TC is poorly investigated and still unclear The aim of this study is to evaluate the possible role of old and new generation endocrine disruptors in thyroid cancer The primary aim is to evaluate the difference in the average levels of the main endocrine disruptors PFAS including PFOA PFOS PFDA PFUnA PFHpS and possibly subsequently other categories such as bisphenols phthalates parabens PCBs flame retardants between patients with and without a diagnosis of thyroid cancer through highly sensitive selective and precise mass spectrometry methods such as liquid chromatography combined with tandem mass spectrometry LC-MS MS
The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied for example the type of diet the use of personal care products
The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied for example the type of diet the use of personal care products
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None